Product Name | MF | CAS | Details |
---|
CBP/p300 ligand 2 | C27H34F2N8O | 2484741-78-6 | Details |
BTK inhibitor 19 | C25H24F3N7O3 | 2557174-19-1 | Details |
(Rac)-5-Hydroxymethyl Tolterodine hydrochloride | C22H32ClNO2 | 250214-40-5 | Details |
Ascochlorin A | C23H31ClO4 | 2550720-02-8 | Details |
eIF4E-IN-3 | C34H30ClF3N6O4S | 2573979-29-8 | Details |
nAChR agonist 2 | C11H16N2 | 252870-46-5 | Details |
MEK4 inhibitor-1 | C13H10FN3O2S | 2570386-36-4 | Details |
PI3Kγ inhibitor 5 | C28H32F2N6O4 | 2566569-31-9 | Details |
BMS-986251 | C30H29F8NO5S | 2460133-35-9 | Details |
CRA-2059 | C34H46N12O8 | 256649-36-2 | Details |
TC-2559 difumarate | C16H22N2O5 | 2454492-41-0 | Details |
HPK1-IN-20 | C26H28N6O2 | 2561490-78-4 | Details |
EGFR-IN-15 | C24H25BrN6O2 | 2573869-16-4 | Details |
SARS-CoV-2-IN-7 | C14H8F3NOSe | 2570461-66-2 | Details |
Pom-8PEG | C29H43N3O12 | 2488761-03-9 | Details |
MPO-IN-1 | C24H21ClN4 | 2471981-21-0 | Details |
IL-17A inhibitor 2 | C24H25F7N8O4 | 2452464-77-4 | Details |
BRD4-IN-2 | C43H48N8O11 | 2679925-55-2 | Details |
MrgprX2 antagonist-3 | C16H20FN3O2S | 2642174-19-2 | Details |
PROTAC IRAK3 degrade-1 | C47H63N11O6 | 2712600-00-3 | Details |
SARS-CoV-2-IN-11 | C27H40F2N3NaO8S | 2722635-28-9 | Details |
DS45500853 | C18H20O3 | 2735803-28-6 | Details |
PLK1-IN-2 | C24H27FN8OS | 2640254-52-8 | Details |
EZH2-IN-6 | C31H41N5O3S | 2702269-27-8 | Details |
CDK5-IN-1 | C24H25FN6O3S | 2639540-19-3 | Details |
Ghrelin receptor full agonist-2 | C26H28ClN5O5S | 2602452-73-1 | Details |
JNK3 inhibitor-1 | C21H17ClFN5O2S | 2622877-97-6 | Details |
Adenosine receptor antagonist 1 | C22H15ClFN7O | 2682930-40-9 | Details |
PIM-IN-1 | C15H18ClFN4O | 2698319-19-4 | Details |
TTBK1-IN-1 | C18H19N5O2 | 2735015-60-6 | Details |
PTPN22-IN-1 | C26H21N3O5 | 2580935-57-3 | Details |
PRMT5-IN-9 | C25H23F3N6O | 2691869-52-8 | Details |
Sarizotan | C22H21FN2O | 351862-32-3 | Details |
IRE1α kinase-IN-6 | C25H23Cl2FN6O3S2 | 2715123-88-7 | Details |
Antifungal agent 14 | C18H19N7O3 | 2710259-38-2 | Details |
PARP/EZH2-IN-1 | C43H41FN8O5 | 2687273-52-3 | Details |
MrgprX2 antagonist-1 | C15H15F5N4O2S | 2642162-06-7 | Details |
CDK7/9-IN-1 | C24H32F3N5O2 | 2747919-19-1 | Details |
DHPS-IN-1 | C17H13BrClN3O2 | 2643300-54-1 | Details |
SW083688 | C23H25N3O5S | 422281-45-6 | Details |
FXR/TGR5 agonist 1 | C31H32ClN3O3 | 2677689-72-2 | Details |
ITK/TRKA-IN-1 | C25H30F2N6O2 | 2655557-54-1 | Details |
FATP1-IN-2 | C19H20FN5O | 2650944-83-3 | Details |
Thalidomide-O-C8-NH2 hydrochloride | C21H28ClN3O5 | 2636798-38-2 | Details |
IL-17A modulator-1 | C33H31N5O4 | 2748749-29-1 | Details |
CDK12-IN-6 | C20H21F2N9 | 2651196-71-1 | Details |
DHODH-IN-18 | C21H16ClF5N6O4 | 2685799-97-5 | Details |
ACAT-IN-6 | C31H47N3O5S | 454203-45-3 | Details |
TRPV4 antagonist 3 | C20H18F4N4O3S | 2681273-35-6 | Details |
PDE4-IN-3 | C35H33FO8 | 2755687-49-9 | Details |
PD0325901-O-C2-dioxolane | C18H16F3IN2O4 | 2581116-22-3 | Details |
JH-XVI-178 | C22H22ClN7O | 2648453-53-4 | Details |
SARS-CoV-2-IN-10 | C27H37F2N3O5 | 2722634-95-7 | Details |
XVA143 | C25H21Cl2N3O8 | 264275-77-6 | Details |
FgGpmk1-IN-1 | C19H16N6O2 | 319490-29-4 | Details |
ACAT-IN-3 | C25H36N2O6S | 454203-25-9 | Details |
Maltoheptaose hydrate | C42H74O37 | 331748-09-5 | Details |
γ-Secretase modulator 10 | C25H23F3N4O2 | 2694817-84-8 | Details |
Mal-PEG2-NHS | C14H16N2O8 | 329364-72-9 | Details |
Thiophene-2 | C18H14F5NO3S | 420089-51-6 | Details |
3'-Deoxy-3'-amino-ATP | C10H17N6O12P3 | 4209-30-7 | Details |
Namoline | C10H3ClF3NO4 | 342795-11-3 | Details |
BMS-986121 | C15H9Cl2N3O2S | 313671-26-0 | Details |
PDE2A-IN-1 | C23H22F2N6 | 2648290-28-0 | Details |
IBS008738 | C22H22N4O2 | 385425-03-6 | Details |
Ftase inhibitor III | C24H34N6O | 2710375-18-9 | Details |
CBP/p300-IN-14 | C30H31F2N7O2 | 2725036-10-0 | Details |
KRAS mutant protein inhibitor 1 | C31H27Cl3FN7O2 | 2642305-16-4 | Details |
Thio-ITP | C10H15N4O13P3S | 27652-34-2 | Details |
Mcl-1 inhibitor 6 | C26H28ClNO6S | 2598978-56-2 | Details |
Dihydrochlamydocin | C28H40N4O6 | 52574-64-8 | Details |
Lesogaberan napadisylate | C13H17FNO5PS | 477956-38-0 | Details |
Carboxylesterase-IN-1 | C30H37BrN2O5 | 2609018-59-7 | Details |
Plasma kallikrein-IN-1 | C23H25F2N7O | 2691030-28-9 | Details |
T-2513 | C25 H27 N3 O5 | 288247-87-0 | Details |
GSK232 | C21H27ClN6O3S | 2702984-69-6 | Details |
TNF-α-IN-6 | C26H25N9O2 | 2699704-20-4 | Details |
ACAT-IN-4 | C32H50N2O5S | 454203-56-6 | Details |
SGC-CK2-1 | C20H21N7O | 2470424-39-4 | Details |
MrgprX2 antagonist-2 | C17H16F5N3O3 | 2642346-30-1 | Details |
CDK7-IN-7 | C20H20BrF3N6O2 | 2640208-01-9 | Details |
KRAS G12D inhibitor 7 | C32H38N8O3 | 2648552-34-3 | Details |
FTO-IN-2 | C15H12N2O2 | 2585198-85-0 | Details |
CDK12-IN-4 | C20H20F2N8O | 2651196-69-7 | Details |
ANAT?inhibitor-1 | C11H16N4O3S | 331751-78-1 | Details |
αvβ5 integrin-IN-1 | C25H28F3N3O3 | 2615912-33-7 | Details |
GPR30 agonist-1 | C19H17BrFNO | 415919-74-3 | Details |
iHCK-37 | C30H32N4O2S2 | 516478-09-4 | Details |
KRAS G12D inhibitor 6 | C32H37ClN8O2 | 2648552-32-1 | Details |
ACAT-IN-10 | C35H56N4O5S | 454203-40-8 | Details |
KRAS G12C inhibitor 18 | C25H20ClFN4O3S | 2649788-45-2 | Details |
ThrRS-IN-2 | C16H10Br2N4O3S | 468750-19-8 | Details |
KIF18A-IN-1 | C28H40N4O5S2 | 2600559-12-2 | Details |
eIF4E-IN-1 | C33H28ClF3N6O4S | 2573979-31-2 | Details |
FAK-IN-1 | C24H26F3N7O4S | 2553215-22-6 | Details |
FNC-TP | C9H14FN6O13P3 | 2457357-99-0 | Details |
CDK2-IN-7 | C24H30N6O4S | 2498658-13-0 | Details |
AXC-715 hydrochloride | C18H26ClN5 | 2490497-93-1 | Details |
MrgprX2 antagonist-5 | C19H13ClF2N4O2S | 2527815-74-1 | Details |
PRMT5-IN-12 | C32H40N4O4 | 2568927-94-4 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 |